Elucidation of underlyingmechanism of MKL1-mediated induction of cancer associated fibroblasts and its clinical applications
Project/Area Number |
17H01401
|
Research Category |
Grant-in-Aid for Scientific Research (A)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Tumor biology
|
Research Institution | Keio University |
Principal Investigator |
Saya Hideyuki 慶應義塾大学, 医学部(信濃町), 教授 (80264282)
|
Co-Investigator(Kenkyū-buntansha) |
信末 博行 慶應義塾大学, 医学部(信濃町), 特任助教 (90525685)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥42,640,000 (Direct Cost: ¥32,800,000、Indirect Cost: ¥9,840,000)
Fiscal Year 2019: ¥12,220,000 (Direct Cost: ¥9,400,000、Indirect Cost: ¥2,820,000)
Fiscal Year 2018: ¥12,220,000 (Direct Cost: ¥9,400,000、Indirect Cost: ¥2,820,000)
Fiscal Year 2017: ¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
|
Keywords | がん関連線維芽細胞 / アクチン細胞骨格 / MKL1 / 癌関連線維芽細胞 / 骨肉腫 / MKL / アクチン / がん微小環境 / 腫瘍関連線維芽細胞 / 微小環境 / 分化 / 腫瘍微小環境 / Rhoキナーゼ阻害剤 |
Outline of Final Research Achievements |
In various stromal cells (fibroblasts, mesenchymal progenitor cells, and adipocytes), conditioned medium obtained from cultured osteosarcoma cells enhanced the activation of megakaryoblastic leukemia 1 (MKL1) which is a transcriptional regulator as well as induced the transition of these cells to cancer-associated fibroblasts (CAFs). We induced expression of MKL1 in various stromal cells and found that they increased expression of CAF-related genes and acquired CAF phenotypes. We also found that the interaction with serum response factor (SRF) is required for MKL1-induced CAF differentiation. In addition, we found that Rho-kinase inhibitor fasudil prevented nuclear translocation of MKL1 via actin dynamics and suppressed CAF differentiation as well as tumor formation in mouse osteosarcoma model. These findings suggest that MKL1 is a master regulator of the transition of stromal cells to CAFs and blocking CAF differentiation may provide a novel therapeutic approach for cancers.
|
Academic Significance and Societal Importance of the Research Achievements |
転写因子あるいは転写制御シグナルを標的とした薬剤が見出されていない現状において、本研究成果は、アクチン細胞骨格の動態を低分子化合物によって変化させることでMKL1および転写因子を調節し、それによってCAFへの分化を阻害し微小環境制御により腫瘍抑制するという先駆的治療法の開発の可能性を見出しており、学術的に新しい概念を生み出すだけでなく、社会的意義も極めて大きい。
|
Report
(4 results)
Research Products
(21 results)
-
-
-
-
-
-
[Journal Article] EGFR promotes glioma progression by regulating xCT and GluN2B-containing NMDA receptor signaling.2018
Author(s)
Suina K, Tsuchihashi K, Yamasaki J, Kamenori S, Shintani S, Hirata Y, Okazaki S, Sampetrean O, Baba E, Akashi K, Takahashi F, Takahashi K, Saya H, Nagano O.
-
Journal Title
Cancer Science
Volume: 109
Issue: 12
Pages: 3874-3882
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.2018
Author(s)
Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, Hadano S, Aoki M, Saya H, Sobue G, Okano H.
-
Journal Title
Nat Med.
Volume: 24
Issue: 10
Pages: 1579-1589
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B cell acute leukemia.2017
Author(s)
Ishizawa J, Sugihara E, Kuninaka S, Mogushi K, Kojima K, Benton CB, Zhao R, Chachad D, Hashimoto N, Jacamo RO, Qiu Y, Yoo SY, Okamoto S, Andreeff M, Kornblau SM, Saya H.
-
Journal Title
Blood
Volume: 129
Issue: 14
Pages: 1958-1968
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.2017
Author(s)
Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, Joyce LN, Kalpana R, Tay ST, Suzuki Y, Cho BC, Kuroda D, Arima K, Izumi D, Iwatsuki M, Baba Y, Oki E, Watanabe M, Saya H, Hirakawa K, Baba H, Tan P.
-
Journal Title
Gastroenterology
Volume: in press
Issue: 1
Pages: 191-204
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407).2017
Author(s)
Shitara K, Doi T, Nagano O, Fukutani M, Hasegawa H, Nomura S, Sato A, Kuwata T, Asai K, Einaga Y, Tsuchihashi K, Suina K, Maeda Y, Saya H, Ohtsu A.
-
Journal Title
Gastric Cancer
Volume: 20
Issue: 6
Pages: 1004-1009
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.2017
Author(s)
Kasai S, Furuichi Y, Ando N, Kagami K, Abe M, Nakane T, Goi K, Inukai T, Saitoh S, Ohno S, Okazaki S, Nagano O, Saya H, Sugita K.
-
Journal Title
Cell Death and Disease
Volume: 8
Issue: 6
Pages: e2857-e2857
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
[Journal Article] Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.2017
Author(s)
Otsubo K, Nosaki K, Imamura CK, Ogata H, Fujita A, Sakata S, Hirai F, Toyokawa G, Iwama E, Harada T, Seto T, Takenoyama M, Ozeki T, Mushiroda T, Inada M, Kishimoto J, Tsuchihashi K, Suina K, Nagano O, Saya H, Nakanishi Y, Okamoto I.
-
Journal Title
Cancer Science
Volume: 108
Issue: 9
Pages: 1843-1849
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Stat3 as a potential therapeutic target for rheumatoid arthritis.2017
Author(s)
Oike T, Sato Y, Kobayashi T, Miyamoto K, Nakamura S, Kaneko Y, Kobayashi S, Harato K, Saya H, Matsumoto M, Nakamura M, Niki Y, Miyamoto T.
-
Journal Title
Sci Rep.
Volume: 7
Issue: 1
Pages: 10965-10965
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-